Chip stocks fall with Nvidia after data center rev disappointment
In a recent transaction, Kirk Thomas F, a director at Myomo, Inc. (NYSE:MYO), purchased 7,400 shares of the company’s common stock. The shares were acquired in a single lot on March 13, 2025, at a price of $5.00 per share, amounting to a total investment of $37,000. Following this transaction, Thomas now holds 255,933 shares in the company. The timing of this purchase appears strategic, as InvestingPro data shows the stock has gained nearly 13% in the past week, though it’s currently trading above its Fair Value. This purchase was executed in an open market transaction, reflecting Thomas’s continued investment in Myomo, a company specializing in orthopedic, prosthetic, and surgical appliances and supplies. The company maintains strong financial health with a current ratio of 3.22 and impressive revenue growth of 69% over the last twelve months. Want deeper insights? InvestingPro offers 8 additional key tips and a comprehensive analysis report for Myomo.
In other recent news, Myomo Inc . reported impressive financial results for the fourth quarter of 2024, with revenue reaching $12.1 million, a 154% increase from the previous year, and surpassing the expected $9.9 million. The company also reported a net loss of $0.01 per share, which was better than the anticipated loss of $0.02 per share. The company’s gross margin improved to 71%, and it achieved its first positive Adjusted EBITDA of $200,000. H.C. Wainwright responded to these results by raising Myomo’s stock price target to $9.50, maintaining a Buy rating. The firm’s confidence is bolstered by Myomo’s financial stability, with $25 million in cash and cash equivalents at the end of the quarter. Myomo’s expansion plans include increasing its reach in Medicare and international markets, which supports future growth prospects. Revenue guidance for 2025 is projected between $50 million and $53 million, indicating a growth rate of 54% to 66%.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.